Xenon Pharmaceuticals (NASDAQ:XENE) Price Target Raised to $64.00 at Wedbush

Xenon Pharmaceuticals (NASDAQ:XENE) Price Target Raised to $64.00 at Wedbush

Wedbush increased their target price on Xenon Pharmaceuticals from $47.00 to $64.00 and gave the company an "outperform" rating in a research note on Tuesday.

Xenon Pharmaceuticals (NASDAQ:XENE) Price Target Raised to $68.00 at Wells Fargo & Company

Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report) had its price objective increased by analysts at Wells Fargo & Company from $49.00 to $68.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Wells Fargo & Company‘s price target indicates a potential upside of 12.69% […]

Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price Expected to Rise, Wedbush Analyst Says

Xenon Pharmaceuticals (NASDAQ:XENE – Get Free Report) had its price objective raised by equities researchers at Wedbush from $47.00 to $64.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the biopharmaceutical company’s stock. Wedbush’s price target points to a potential upside of 1.98% from the […]